Skip to main content
PMC home page
Cancer Management and Research logoLink to Cancer Management and Research
. 2019 Sep 16;11:8407–8418. doi: 10.2147/CMAR.S218214

Mechanisms Underlying Therapeutic Effects Of Traditional Chinese Medicine On Gastric Cancer

Linjun Yang 1,*, Liqian Zhao 1,*, Tianni Zeng 1, Hong Chen 1, Jingjing Shao 1, Song Yang 1, Zheying Tao 1, Jingqin Yang 1, Tongke Chen 1, Xiaokun Lin 2, Xiwen Chen 1,✉, Mosheng Tang 3,✉
PMCID: PMC6754335  PMID: 31571996

Abstract

Gastric cancer (GC) is one of the most common malignant tumors in the world. It is the fourth most common cancer and has the second highest mortality rate globally. Metastasis is an important feature of gastric cancer and is the most common cause of death. Exploring the mechanism underlying the metastasis of gastric cancer and searching for new drug targets has become the focus of several studies. Traditional Chinese medicine may show promise for treatment of gastric cancer. In this review, we report the recent progress in research on the anti-metastasis activity of Chinese medicine, to facilitate clinical development of treatments for gastric cancer.

Keywords: Chinese medicine, metastasis, gastric cancer, cell cycle, angiogenesis

Introduction

Gastric cancer is the most common malignant tumor of the digestive system. China accounts for 42.6% of gastric cancer cases globally,1 and one of the main causes of death is metastasis of malignant tumors.2 With the continuous study of traditional Chinese medicine, numerous studies have illuminated that in cancer treatment it can be used to enhance the efficacy and diminish the side effects. Chen et al.3 Found that Huaier make the effective of HCC after curative liver resection which can extend RFS and reduce extrahepatic recurrence. In addition, Von Hagens et al.4 illustrated that in a phase I study, patients who have metastatic breast cancer with Long-term oral artesunate can consolidate the original curative effect and safety. Deeken et al.5 indicated that intravenous artesunate is 18 mg/kg which the treatment of solid tumor was well tolerated and diminishing the side effect. Compared to chemotherapy and radiotherapy in Western medicine, traditional Chinese medicine places considerable emphasis on overall regulation, and it has been proved to be an effective therapy for reducing side effects, improving the survival rate, and prolonging the survival period in cancer model systems. There are some anti-radiation traditional Chinese medicine in radiotherapy.6 Traditional Chinese medicine is proved to be efficacious in increasing the sensitivity to chemo- and radio-therapies.7 And evidence from the meta-analysis suggested that traditional Chinese medicine combined with chemotherapy has a positive effect on gastric cancer treatment.8 It can be seen that traditional Chinese medicine is of great significant for assitant-therapy to decline the side effect, safe and tolerable. The purpose of this review is to clarify the mechanism by which traditional Chinese medicine helps in the treatment of gastric cancer and prevention of metastasis as shown in Table 1.

Table 1.

Traditional Chinese Medicine On Gastric Cancer

Ingredients of TCD TCD Experiment Gastric cancer cell line and Experimental animal Dosage Event/Mechanism Effect Refs&PMID
Prescriptions Xiaotan Sanjie recipe In vivo BALB/C nude mice
(5×106 MKN-45)		 1.496g VEGF-C and VEGFR-3 Metastasis 37
21425575
Herbs Luteolin In vitro MGC-803, HUVECs, Hs-746T 10、20、30 μM

(Main 30 μM)		 Suppressed Notch1-VEGF signaling

Regulated NF-kB, AKT, and MMP-9 signaling		 Angiogenesis and VM formation
Metastasis		 32

28655612
Tanshinone IIA (TSN) In vitro SGC-7901 1、5、20 μg/L Downregulation of FOXM1 Proliferation and Migration 50
28184921
Baicalein In vitro SGC-7901, MKN45 15、30、60 μmol/L Regulated Bcl-2 and Bax
Mitochondrial pathway		 Growth arrest
Apoptosis		 54
26918059
In vivo BALB/c nude mice
(1×106 SGC-7901)		 15、50 mg/kg
Baicalein In vitro SGC-7901 and MGC-803 <80 µM p38 Invasion 44
25502212
Crude extracts Coleusin factor (CF) In vitro BGC-823 25、50、100 μM G0/G1
Decreased cyclinD1, Bcl-2, and Bcl-xL, increased the p53, p21, and Rb.		 Growth arrest
Proliferation and Apoptosis		 12
21093146
Berberine hydrochloride (BER) In vitro AGS 15 μM G2/M
Enhanced IL −8 expression
Affected ERK1/2, SAPK/JNK, JAK2 and AP-1 pathway		 Growth arrest
Proliferation and Metastasis		 13
24063987
Ailanthone In vitro SGC-7901 0.5、1、2、4、 8 µM G2/M
Bcl-2 and Bax		 Growth arrest
Apoptosis		 14
None
Celastrus Orbiculatus extract (COE) In vitro AGS and BGC-823 160 mg/L PI3K/Akt/mTOR/p70s6k pathway
Induced the caspase-dependent mitochondrial pathway		 Proliferation
Apoptosis		 20
28476678
In vivo Nude mice(GFP GC cells) 40 mg/kg
Xiaotan Sanjie decoction In vitro GCSCs and MKN-45 1. 46、2.92 and 5.84 g/mL Notch-1、Hes1、VEGF and Ki-67 Metastasis 34
25278704
In vivo Sprague-dawley rats and nude mice
(1×106 CD44+ and CD44- cells)		 1. 46、2.92 and 5.84 g/mL
Yiqi Huayu Jiedu decoction In vitro MGC-803 2 mg/mL TGF-β/Smad Invasion and Metastasis 39
28539961
In vivo BALB/C nude mice
(5×106 MGC-803)		 4 g/mL, 2 g/mL
Aqueous Huaier Extract In vitro SGC-7901 and MGC-803 0.1、 0.2、 0.3、 0.5 mg/mL
(main 0.5 mg/mL)		 Decreased N-cadherin and vimentin Metastasis 48


29151976
In vivo Zebrafish
(3×102 SGC-7901 labeled with CM-Dil)		 1 mg/m
Celastrus Orbiculatus extract (COE) In vitro MGC-803 20、40、80 µg/mL Promoted the expression of maspin Phosphoinositide 3-kinase/Akt/mTOR and MAPK signaling pathways Apoptosis
Invasion and Migration		 55
29387218
Compounds Matrines In vitro SGC-7901 0.25、0.5、1.0、2.0 mg/mL G0/G1
Bax		 Growth arrest
Apoptosis		 10
21519796
Gambogic acid (GA) In vitro BGC-823 1.4 μM Repressed hTERT transcriptional activity via c-Myc and Akt Telomerase activity 18
18226852
Crocodile choline (CCL) In vitro BGC-823, MGC-803, SGC-7901, MKN28 and GES1 10、20、40、60 µg/mL G2/M
ΔΨm and ROS
Notch pathway		 Growth arrest
Apoptosis
Proliferation and Metastasis		 22

28347224
In vivo BALB/C nude mice
(1×106 BGC-823)		 100 mg/kg
Ginsenoside In vivo BALB/C nude mice
(5×106 NUGC-4-RFP)		 1 mg/kg VEGF-C, VEGF-D and VEGFR-3 Proliferation and Metastasis 36
28314255
Matrine In vitro BCG-823 50 μg/mL Affected vasodilator-stimulated phosphoprotein (VASP) Migration 45
23685951
Silibinin In vitro SGC-7901 50、100、200 μM Decreased MMP-2 and MMP-9 Migration and Invasion 43
29344204
Astragalus polysaccharide In vitro AGS 200 μg/mL Inhibited phosphorylated AKT (p-AKT) and MMP-9 Metastasis 49
29428665
Naringenin In vitro SGC-7901 20、40、80 μM Regulated AKT pathway Proliferation, Apoptosis, Migration, and Invasion 52
26960693
Components Piperlongumine (PL) In vitro AGS and HGC-27 5、7.5、10 μM
(Main 7.5 μM)		 G2/M
Mediated by ROS and involves GADD45α, XIAP, and CHOP.
Suppressed STAT3 and TERT		 Growth arrest
Proliferation and
Apoptosis		 19
26874726
In vivo Nude mice
(2×106 HGC-27)		 3.6 mg/kg
Pseudolaric acid B (PAB) In vitro BGC-823 and MKN-45 0.5、 2、5 、10 μM
(10 μM)		 Suppressed PI3K/AKT, ERK1/2 and mitochondrial signaling

Regulated MMP-9, HIF 1α, VEGF, VEGFR2, E-Cadherin and Ezrin		 Apoptosis


Metastasis		 21


28132880
In vivo BALB/C nude mice(1×106 BGC-823) 30 mg/kg
Curcumin In vitro BGC-823 15 μmol/L Regulated JNK-MAPK signal pathway Growth arrest 61
25292057
Curcumin In vitro MKN45, AGS, GES-1 3.125、6.25、12.5、25.0 、50.0 μmol/L Regulated Cox-2 and NF-kB pathway Growth arrest 63
25884903
(-) - patchouli alcohol (PA) In vitro GES-1 10 μM Decreased IL-4,IL-2,TNF-alpha Increased IL-13 Growth arrest 64
27017292
Curcumin In vitro GC-MSCs 30 μmol/L Inhibited NF-κB/VEGF
signaling		 Angiogenesis and Metastasis 33
29312505
Green tea polyphenols In vitro MKN-28 10-4 M catechin equivalents Inhibited MMP-2、MMP-9 Migration and Invasion 42
29450132
Dehydroeffusol In vitro SGC-7901 and AGS 12、24、48 μM Regulated VE-cadherin and MMP-2 Adhesion, Migration, and Invasion 53
25982451
In vivo BALB/C nude mice
(4×106 SGC-7901)		 40、120 μg
Open in a new tab

Inhibition Of Proliferation Of Gastric Cancer Cells

The proliferation of tumor cells is the foundation of tumor invasion and metastasis. Excessive proliferation of tumor cells at the primary focal center increases pressure and promotes invasion and metastasis in the direction of low pressure, resulting in metastasis to neighboring tissue and distant organs. Traditional Chinese medicine and its components can suppress the proliferation of gastric cancer by arresting the cell cycle, inhibiting telomerase activity, inducing apoptosis via the mitochondrial pathway, and regulating inflammation-related factors.

Cell Cycle Arrest

Uncontrolled cell proliferation is one of the fundamental biological characteristics of tumors, based on dysregulation of the cell cycle. Various tumor components operate through cell cycle arrest. Cell cycle-dependent kinase (CDK2 and CDK4) plays a key role in cell cycle progression and is closely related to the entry of cells into S and G1 phase.9 Cell cycle arrest of tumor cells by traditional Chinese medicine is related to the loss of cell cycle-dependent protein kinase inhibitory factor activity, thereby inhibiting the CDK suppression signal and leading to cell cycle regulation disorder. Several studies have reported that10,11 matrines (including sophocarpine, oxysophocarpine, and sophoridine), astragalus polysaccharides (including ascorbic acid, glucose, and fructose), and cinobufotalin (an anti-cancer drug) can induce G1 cycle arrest. Sun et al.12 found that Coleusin factor induced cell cycle arrest at the G0/G1 stage in SGC-7901 cells. Other studies13,14 reported that berberine and ailanthone induced G2/M cell cycle arrest and inhibited the proliferation of gastric cancer cells.

Inhibition Of Telomerase Activity

Recent studies have discovered that telomerase is expressed in more than 85% of cancers, making telomerase an attractive and viable target for the development of anti-cancer therapeutics.15,16 Telomerase may play an important role in the process of tumor proliferation. Moreover, inhibiting tumor cell telomerase activity through traditional Chinese medicine can effectively inhibit tumor cell proliferation and interfere with metastasis of tumor cells.

Çalışkan et al.17 found that telomerase activity regulates the expression of human telomerase reverse transcriptase (hTERT) in gastric cancer cells, and suggested that inhibiting telomerase activity may be a potential anti-cancer therapeutic mechanism. Another study18 utilized the PCR-TRAP method to evaluate telomerase activity in BGC-823 human gastric carcinoma cells, and found that gambogic acid (GA) can inhibit telomerase activity by inhibiting the phosphorylation of Akt and reducing the expression of hTERT. Duan et al.19 demonstrated that piperlongumine (PL) acts as an anti-cancer agent by inhibiting telomerase activity and cell proliferation in vitro and in vivo.

Mitochondrial Apoptosis Pathway

Wang et al.20 found that the ethyl acetate extract of Celastrus orbiculatus (C. orbiculatus extract, COE) could change the mitochondrial membrane potential of the cell, downregulate the apoptosis-related proteins Bax and caspase, and increase the expression of bcl-2 and PI3K/Akt. These data suggest that the COE may inhibit the proliferation and metastasis of gastric cancer cells by inducing apoptosis. Pseudolaric acid (PAB) has been shown to promote the apoptosis of various cells. Wang et al.21 evaluated the molecular mechanism of the antitumor activity of PAB in human leukemia U937 cells. U937 cells were observed to be activated by the Bcl-2-mediated mitochondrial pathway, and activation of the caspase-dependent pathway was regulated by PAB. In addition, the activity of caspase-3 increased after PAB treatment. This study thus showed that PAB can enhance U937 cell apoptosis, at least in part through the activation of the mitochondrial apoptotic pathway. Mao et al.22 found that crocodile bile accelerated cell apoptosis via the mitochondrial apoptosis pathway. Simultaneously, it reduced the mitochondrial membrane potential, and increased the production of reactive oxygen species, the Bax/Bcl-2 ratio, the levels of activated caspase-3, and the release of cytochrome C. These data indicate that crocodile choline is a potent inhibitor of gastric cancer cells via the mitochondrial apoptosis pathway.

Other Aspects

The literature shows that traditional Chinese medicine also exhibits anti-gastric cancer effects through autophagy.23 Curcumin24 may inhibit proliferation and induce the autophagy and apoptosis in GC cells through MTT assay and transmission electron microscopy (TEM). Lei25 find that mulberry anthocyanins intervented SGC-7901 cells induced autophagy byTEM observation results.

Some studies have shown that traditional Chinese medicine can inhibit the effect of tumor cells through ROS. Kim DH et al26 reported for the first time that ISL induces apoptosis of renal cell carcinoma Caki cells by producing ROS, thus inducing p53 and inhibiting Stat3 signaling pathway. Silybin27 can induce caspase-dependent cell death in vitro and inhibit the growth of glioma in vivo through Ca2+/ROS/MAPK-mediated pathway.

There are other natural products, bitter melon extract (BME), suppressing the cancer proliferation via different mechanisms. Bhattacharya et al.28 shown that BME enhances NK cell-mediated HNSCC killing activity and reveals the potential immunomodulatory effects of BME. Muhammad et al.29 found that BME attains anti-tumor activity by induction of autophagy and AMPK/mTOR pathway. Subsequently, they demonstrated that BME oral feeding effectively inhibited cancer cell growth in isogenic and xenograft mouse models. In addition, Bhattacharya et al.30 shown that BME inhibited cell proliferation in BME orally-fed mouse tumors via lowering expression of proliferating cell nuclear antigen (PCNA) and c-Myc. Both of their studies indicates BME high potential clinical application.

Interference With Angiogenesis

By co-culturing endothelial cells with human or animal macrophages or supernatants, it was found that the angiogenic extracts caused chemotaxis of the peritoneal macrophages and human mononuclear cells in guinea pigs. These results imply that tumor extracts act indirectly to induce angiogenesis in vivo via their effect on host macrophages.31 Angiogenesis can be controlled by inhibiting the proliferation of vascular endothelial cells (VECs) and by regulating vascular growth factors.

Inhibition Of The Proliferation Of VECs

Angiogenesis is an essential pathological process in the metastasis of malignant tumors, and endothelial cell proliferation is the basis of angiogenesis. Therefore, the discovery and screening of drugs that inhibit the proliferation of VECs has become a focus of tumor clinical research. Zang et al.32 reported that Luteolin has an inhibitory effect on gastric cancer angiogenesis and Vasculogenic mimicry (VM) formation induced by inhibiting VEGF secretion, which is dependent on Notch1 expression. Huang et al.33 observed that curcumin could inhibit GC-MSC driven angiogenesis, which inhibits the proliferation of vascular endothelial cells, producing an anti-tumor effect. Lynne M Howells et al supported that in the treatment of patients with metastatic colorectal cancer. Curcumin is well safety and tolerated combining with FOLFOX chemotherapy. Bing et al.34 reported that Xiaotansanjie decoction attenuates microvessel density by inhibiting the proliferation of vascular endothelial cells in gastric cancer.

Angiogenic Factors

Under conditions of local hypoxia, several molecular responses are induced during tumor growth which activate hypoxia-inducible factors. The transcription factor HIF accumulates in endothelial cells under hypoxic conditions and binds to the VEGF promoter to induce VEGF expression, resulting in angiogenesis.35 Dai et al.36 reported that Ginsenoside Rg3 inhibits tumor growth and reduces lymph node metastasis by inhibiting the expression of VEGF-C, VEGF-D, and VEGFR-3 in an orthotopic mouse model of human gastric cancer. Pang et al.37 reported that xiaotan sanjie can inhibit proliferation of human gastric adenocarcinoma cells MKN-45 by attenuating tumor angiogenesis, which may be related to downregulation of the mRNA and protein expressions of VEGF-C and VEGFR-3.

Inhibition Of Gastric Cancer Cell Movement

Local invasion and distant metastasis are the most important biological features of malignant carcinoma. Tumors with invasive growth can not only continue to grow at the original site, but also spread directly to the surrounding tissue, and can also spread to other parts of the body through a variety of ways. Therefore, inhibiting the metastasis of gastric cancer cells is particularly important in the treatment of tumor, including inhibition of the migration and invasion of gastric cancer cells and the adhesion of gastric cancer cells.

Migration And Invasion

The migration and invasion capabilities of gastric cancer cells are associated with metastasis.38 Once proliferating gastric cancer cells reach a certain density, they will invade the adjacent basement membrane and extracellular matrix, penetrate blood vessels, and enter the circulatory system. Via migration through blood vessels, a small metastasis focus will be formed on a target organ.39 Other studies have also indicated that MMP-2 and MMP-9 facilitate cell migration and invasion. MMP-2 is involved in the metabolism of type IV collagen in the basement membrane, which is often the initial step in cancer invasion and metastasis.40,41 In addition, MMP-9, which is the main enzyme for degrading extracellular matrix (ECM), is an important mediator of migration and invasion for gastric cancer cells.42 Lu et al.43 reported that Silibinin acts by inhibiting the invasion and metastasis of human gastric cancer SGC-7901 cells, and by downregulating MMP-9 and MMP-2. Yan et al.44 found that Baicalein could inhibit the proliferative, adhesive, invasive, and migratory abilities of SGC-7901 cells. The underlying mechanism was the inhibition of the expression of MMP-9 and MMP-2 by suppressing the activity of the p38 signaling pathway. Zhang et al.45 demonstrated that alisol B can regulate phosphorylation of vasodilator-stimulated phosphoprotein (VASP) to inhibit gastric cancer cell adhesion and migration.

Adhesion

An increase in cell adhesion molecule expression and degradation of the extracellular matrix can control cancer metastasis and reduce migration of cancer cells.

Regulating The Expression Of Adhesion Molecules

Adhesion molecules regulate cell-cell adhesion, as well as adhesion of cells to the extracellular matrix. Reducing adhesion between malignant tumor cells and enhancing adhesion of tumor cells to host cells and the extracellular matrix are two of the basic mechanisms of malignant tumor metastasis. Adhesion is regulated by focal adhesion molecules including CD44 and E-Cad. One of the functions of CD44 is to regulate the adhesion and migration of tumor cells. In the active state, the cytoplasmic domain of CD44 interacts with the actin cytoskeleton, which promotes migration of tumor cells.46 Sun et al.47 found that HepG2 cells cultured with the serum of rats fed with Biejiajian Pills showed lower expressions of β-catenin protein both in the cytoplasm and the nuclei along with the inhibition of GSK-3β phosphorylation and reduced expression of CD44v6 and VEGF. Biejiajian Pills suppress the proliferation and invasiveness of hepatocellular carcinoma. Xu et al.48 found that Huaier could partly reverse the epithelial-mesenchymal transition (EMT) by decreasing the expression of the mesenchymal markers N-cadherin and vimentin and increasing the expression of the epithelial marker E-cadherin. Huaier extract significantly inhibited both the migratory and invasive abilities of gastric cancer cells. Ma et al Indicated that by Comprehensive clinical analysis, Huaier might enhance clinical therapeutic effects and decline the side ones with Gastrointestinal cancers.

Inhibiting Extracellular Matrix Degradation

MMPs are the major zymogen family proteins that degrade tumor extracellular matrix (ECM). MMPs can promote tumor cell invasion of the ECM by degrading it, which permits tumor cells to migrate to other sites. Wu et al.49 found that the combination of Apatinib and AsPs could inhibit the expression of phosphorylated AKT (p-AKT) and MMP-9 expression. Apatinib, in combination with AsPs, showed enhanced inhibitory effects on cell proliferation, migration, and invasion compared with Apatinib monotherapy. Jiao et al.50 found that the migration and proliferation of the SGC-7901 cells were decreased after incubation with different concentrations of Tanshinone IIA (TSN) in a dose-dependent manner. Moreover, the expression levels of Ki-67, PCAN, MMP-2, MMP-9, and FOXM1 were decreased, and P21 was increased in the TSN-treated SGC-7901 cells.

Modulation Of Metastasis-Related Genes To Inhibit Metastasis

Inhibition of gastric cancer cell metastasis can be achieved by regulating metastasis-related gene expression in gastric cancer. In 2003, Ishikawa et al.51 reported that VEGF-C and -D genes may be associated with lymphatic metastasis of early gastric cancer, which suggested that VEGF-C and -D genes inhibit tumor metastasis. Dai et al.36 reported that ginsenosides can target vegf-c, vegf-d, and vegfr-3 genes in mouse models of human gastric cancer cells and inhibit the progression and metastasis of malignant tumors. Bao et al.52 reported that naringenin may inhibit the migration and invasion of human gastric cancer SGC-7901 cells by reducing the expression of metastasis related genes MMP-2 and MMP-9. Liu et al.53 reported that Dehydroeffusol can significantly inhibit the migration and invasion of gastric cancer cells in vivo and in vitro. Dehydroeffusol can inhibit gene promoter activity, influence the expression of the vasculogenic mimicry master gene VE-cadherin, and significantly reduce the expression of metastasis associated genes in gastric cancer cells (MMP2), thus effectively inhibiting gastric cancer metastasis. The proliferation of gastric cancer cells not only increases the pressure between gastric cancer cells, but also enhances metastasis. Most traditional Chinese medicines exhibit their anti-metastasis effect by regulating the relevant oncogenes and anti-oncogenes to further inhibit cellular proliferation and induce apoptosis. Recent studies have demonstrated that metastasis-associated genes include Bcl-2, Bax, maspin, and p53. Mu et al.54 showed that baicalein has anti-apoptotic activity by downregulating Bcl-2 and upregulating Bax in SGC-7901 cells. Qian et al.55 indicated that COE could induce apoptosis of human gastric cancer MGC-803 cells overexpressing the maspin gene.

Regulation Of Inflammation-Related Factors

Cancer-related inflammation can promote tumorigenesis, tumor growth, and tumor metastasis in many types of cancers. Therefore, inhibiting cancer-related inflammation significantly improves the effects of cancer therapy. It is known that neoplastic cells often over-express proinflammatory mediators including proteases, eicosanoids, cytokines, and chemokines.56 Moreover, 40 years ago, the phenomenon of TNF-mediated cell death in vitro and its physiological and pathophysiological effects were first described.57,58 Blocking TNF causes TNFR1 to no longer activate MAPK and NF-κB signaling, resulting in downregulation of proinflammatory genes.59 Curcumin plays an anti-cancer role by inhibiting the occurrence, progression, and metastasis of various cancers, and inhibits cancer by two main processes that affect angiogenesis and tumor growth. Curcumin inhibits lymph node metastasis in gastric cancer, and its pleiotropic activity is mediated by modulating proinflammatory cytokines, and other signaling molecules, Human protein STAT3, NF-κB, COX-2, 5-LOX, C- reactive protein, prostaglandin E (2), prostatic specific antigen, adhesion molecule, phosphorylase kinase, triglyceride, transforming growth factor beta, ET-1 HO-1, creatinine, ALT, and AST.60–63 Patchouli alcohol (PA), the main active ingredient of Pogostemonis herba, has anti-Helicobacter pylori and gastroprotective functions. In addition, PA significantly reduced the levels of pro-inflammatory cytokines such as interleukin −4 (IL-4), IL-2, and tumor necrosis factor (TNF-alpha), and increased the level of the anti-inflammatory cytokine IL-13 in GES-1 cells. To a certain extent, reducing the inflammatory reaction of the gastric mucosa can help block the precancerous lesions of gastric cancer.64

Conclusion

This article summarizes how Chinese medicine can intervene at multiple levels and affect multiple targets to influence the metastasis of gastric cancer as shown in Figure 1. However, it is difficult to confirm the active ingredients of traditional Chinese medicines due to their multimodal anti-tumor effects and complex composition, thus greatly limiting their potential. Additionally, clinical research for traditional Chinese medicine still lacks in-depth study and evaluation criteria, and as a result its authenticity is largely unrecognized. These findings suggest that the multi-effects of traditional Chinese medicine should be combined with those of Western medicine, allowing integrative medicine to be used to control tumors. It is expected that further rigorous research will demonstrate that traditional Chinese medicine has clinical significance for treatment of the metastasis of gastric cancer and will lead to improvement of preventive measures.

Figure 1.

Figure 1

Open in a new tab

Mechanisms underlying therapeutic effects of traditional Chinese medicine on gastric cancer. (A) General approach of mechanisms. (B) Detailed approach of mechanisms.

With the continuous discovery and deeper exploration of the mechanism of gastric cancer and identification of the new molecular targets, the target of Chinese medicine in gastric cancer has been found, and the effects of traditional Chinese medicine have been determined at the molecular level, which provides the basis for clinical applications of traditional Chinese medicine.

Acknowledgments

We thank the grants provided from Natural Science Foundation of China Grant (81673733), Zhejiang Provincial Natural Science Foundation of China Grant (LQ17H120009), College Student Innovation and Entrepreneurship Training Program of China (201710343015).

Author contributions

All authors contributed to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210 [DOI] [PubMed] [Google Scholar]
  • 2.Tsai SC, Huang SF, Chiang JH, et al. The differential regulation of microRNAs is associated with oral cancer. Oncol Rep. 2017;38(3):1613. doi: 10.3892/or.2017.5851 [DOI] [PubMed] [Google Scholar]
  • 3.Chen Q, Shu C, Laurence AD, et al. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial. Gut. 2018. doi: 10.1136/gutjnl-2018-315983 [DOI] [PubMed] [Google Scholar]
  • 4.Von Hagens C, Walter-Sack I, Goeckenjan M, et al. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2). Phytomedicine. 2018;54:140–148. [DOI] [PubMed] [Google Scholar]
  • 5.Deeken JF, Wang H, Hartley M, et al. A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol. 2018;81:587–596. doi: 10.1007/s00280-018-3533-8 [DOI] [PubMed] [Google Scholar]
  • 6.Bo-Shu L, Dong LI, Jin-Ping L, et al. Anti-radiation traditional Chinese medicine and natural products: researchadvances. J Int Pharm Res. 2015;4:453–462. [Google Scholar]
  • 7.Mao X, Zhang Y, Lin N. Application and perspectives of traditional Chinese medicine in the treatment of liver cancer. Cancer Transl Med. 2015;1(3):101. doi: 10.4103/2395-3977.159538 [DOI] [Google Scholar]
  • 8.Yunbo C, Guijuan Z, Xiaoping C, et al. Jianpi Bushen, a traditional Chinese medicine therapy, combined with chemotherapy for gastric cancer treatment: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fisher RP. Getting to S: CDK functions and targets on the path to cell-cycle commitment. F1000research. 2016;5:2374. doi: 10.12688/f1000research [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhang J, Li Y, Chen X, et al. Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells.. Oncol Rep. 2011;26(1):115. doi: 10.3892/or.2011.1266 [DOI] [PubMed] [Google Scholar]
  • 11.Afroze SH, Sloan J, Osuji GC, et al. Cinobufotalin impedes Sw.71 cytotrophoblast cell line function via cell cycle arrest and apoptotic signaling. Mol Cell Biochem. 2016;422(1–2):189. doi: 10.1007/s11010-016-2820-0 [DOI] [PubMed] [Google Scholar]
  • 12.Sun B, Geng S, Huang X, et al. Coleusin factor exerts cytotoxic activity by inducing G0/G1 cell cycle arrest and apoptosis in human gastric cancer BGC-823 cells. Cancer Lett. 2011;301(1):95–105. doi: 10.1016/j.canlet.2010.10.010 [DOI] [PubMed] [Google Scholar]
  • 13.Shi HL, Wu XJ, Liu Y, et al. Berberine counteracts enhancedIL −8 expression of AGS cells induced by evodiamine. Life Sci. 2013;93(22):830–839. doi: 10.1016/j.lfs.2013.09.010 [DOI] [PubMed] [Google Scholar]
  • 14.Chen Y, Zhu L, Yang X, et al. Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells. Mol Med Rep. 2017;16(5):6821–6827. doi: 10.3892/mmr.2017.7491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kosciolek BA, Kalantidis K, Tabler M, et al. Inhibition of telomerase activity in human cancer cells by RNA interference. Mol Cancer Ther. 2003;2(3):209. [PubMed] [Google Scholar]
  • 16.Ivancich M, Schrank Z, Wojdyla L, et al. Treating cancer by targeting telomeres and telomerase. Antioxidants. 2017;6(1). doi: 10.3390/antiox6010015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Çalışkan EC, Atalay MC, Miser ES, et al. Normal and tumour tissue mRNA expressions of telomerase complex genes in several types of cancer. Balkan Med J. 2017;34(3):269–274. doi: 10.4274/balkanmedj.2015.1616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhao Q, Yang Y, Yu J, et al. Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells. Cancer Lett. 2008;262(2):223–231. doi: 10.1016/j.canlet.2007.12.002 [DOI] [PubMed] [Google Scholar]
  • 19.Duan C, Zhang B, Deng C, et al. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo. Tumour Biol. 2016;37(8):1–12. [DOI] [PubMed] [Google Scholar]
  • 20.Wang H, Tao L, Ni T, et al. Anticancer efficacy of the ethyl acetate extract from the traditional Chinese medicine herb Celastrus orbiculatus against human gastric cancer.. J Ethnopharmacol. 2017;205:147–157. doi: 10.1016/j.jep.2017.04.030 [DOI] [PubMed] [Google Scholar]
  • 21.Wang D, Xin Y, Tian Y, et al. Pseudolaric Acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways. Exp Cell Res. 2017;352:34–44. [DOI] [PubMed] [Google Scholar]
  • 22.Mao XM, Fu QR, Li HL, et al. Crocodile cholin from Crocodylussiamensis induces apoptosis of human gastric cancer. Tumour Biol. 2017;39(3):1010428317694320. doi: 10.1177/1010428317694320 [DOI] [PubMed] [Google Scholar]
  • 23.Li Z, Oncology DO. Observation of the preventive effect of compound Kushen injection on chemotherapy adverse reactions in postoperative gastric cancer patients and its effects on immune function. Hebei J Tradit Chin Med 2016;38:42–44. [Google Scholar]
  • 24.Fu H, Wang C, Yang D, et al. Curcumin regulates proliferation, autophagy and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling. J Cell Physiol. 2017;233:4634–4642. [DOI] [PubMed] [Google Scholar]
  • 25.Lei Z, Jie Z, Jun L, et al. Study on mulberry anthocyanins induced autophagy and apoptosis of human gastric cancer SGC-7901 cell autophagy. J Chinese Med Mater. 2016;39:1134–8. [PubMed] [Google Scholar]
  • 26.Kim DH, Park J, Chae I, et al. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway. Oncol Rep. 2017;38:575–583. doi: 10.3892/or.2017.5677 [DOI] [PubMed] [Google Scholar]
  • 27.Kim KW, Choi CH, Kim TH, et al. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo. Neurochem Res. 2009;34(8):1479–1490. doi: 10.1007/s11064-009-9935-6 [DOI] [PubMed] [Google Scholar]
  • 28.Bhattacharya S, Muhammd N, Steele R, et al. Bitter melon enhances natural killer mediated toxicity against head and neck cancer cells. Cancer Prev Res. 2017;10(6):337–344. doi: 10.1158/1940-6207.CAPR-17-0046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Muhammad N, Steele R, Isbell ST, et al. Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death. Oncotarget. 2017;8:39. doi: 10.18632/oncotarget.19887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bhattacharya S, Muhammad N, Steele R, et al. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth. Oncotarget. 2016;7(22):33202–33209. doi: 10.18632/oncotarget.8898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mostafa LK, Jones DB, Wright DH. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies employing bovine aortic endothelial cells in vitro. J Pathol. 1980;132(3):207–216. doi: 10.1002/path.1711320303 [DOI] [PubMed] [Google Scholar]
  • 32.Zang M, Hu L, Zhang B, et al. Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer. Biochem Biophys Res Commun. 2017;490(3):913. doi: 10.1016/j.bbrc.2017.06.140 [DOI] [PubMed] [Google Scholar]
  • 33.Huang F, Yao Y, Wu J, et al. Curcumin inhibits gastric cancer-derived mesenchymal stem cells mediated angiogenesis by regulating NF-κB/VEGF signaling. Am J Transl Res. 2017;9(12):5538–5547. [PMC free article] [PubMed] [Google Scholar]
  • 34.Bing Y, Long L, Ying Z, et al. XiaotanSanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. World J Gastroenterol. 2014;20(36):13105. doi: 10.3748/wjg.v20.i36.13105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ahluwalia A, Jones MK, Tarnawski AS. Key role of endothelial importin-α in VEGFexpression and gastric angiogenesis: novel insight into aging gastropathy. Am J Physiol Gastrointest Liver Physiol. 2014;306(4):338–345. doi: 10.1152/ajpgi.00382.2013 [DOI] [PubMed] [Google Scholar]
  • 36.Dai X, Liu D, Liu M, et al. Anti-metastatic efficacy of traditional Chinese medicine (TCM) ginsenoside conjugated to a VEFGR-3 antibody on human gastric cancer in an orthotopic mouse model. Anticancer Res. 2017;37(3):979. doi: 10.21873/anticanres.11407 [DOI] [PubMed] [Google Scholar]
  • 37.Pang B, Wei PK, Li YJ. Effect of xiaotan sanjie recipe on expressions of VEGF-C and VEGFR-3 in nude mice with transplanted human gastric adenocarcinoma cell MKN-45. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011;31(2):204–208. [PubMed] [Google Scholar]
  • 38.Li Y, Tan BB, Zhao Q, et al. ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells. Neoplasma. 2014;61(3):291. doi: 10.4149/neo_2014_050 [DOI] [PubMed] [Google Scholar]
  • 39.Wu -T-T, Lu J, Zheng PQ, et al. Yiqi Huayu Jiedu Decoction inhibit the invasion and metastasis of gastric cancer cells through TGF-β/Smad pathway. Evid Based Complement Alternat Med. 2017;2017(19):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Łukaszewicz-Zając M, Mroczko B, Guzińska-Ustymowicz K, et al. Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients. Adv Med Sci. 2013;58(2):235–243. doi: 10.2478/ams-2013-0018 [DOI] [PubMed] [Google Scholar]
  • 41.Chen SX, Yin JF, Lin BC, et al. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol. 2016;37(5):6801–6812. doi: 10.1007/s13277-015-4404-0 [DOI] [PubMed] [Google Scholar]
  • 42.Arcone R, Palma M, Pagliara V, et al. Green tea polyphenols affect invasiveness of human gastric MKN-28 cells by inhibition of LPS or TNF-α induced matrix metalloproteinase-9/2. Biochim Open. 2016;3(C):56–63. doi: 10.1016/j.biopen.2016.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lu S, Zhang Z, Chen M, et al. Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway. Oncol Lett. 2017;14(6):7577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Yan X, Rui X, Zhang K. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep. 2015;33(2):737–743. doi: 10.3892/or.2014.3669 [DOI] [PubMed] [Google Scholar]
  • 45.Zhang J, Su K, Shi W, et al. Matrine inhibits the adhesion and migration of BCG823 gastric cancer cells by affecting the structure and function of the vasodilator-stimulated phosphoprotein (VASP). Acta Pharmacol Sin. 2013;34(8):1084–1092. doi: 10.1038/aps.2013.15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC. Interaction between the adhesion receptor, CD44, and the oncogene product, p185 HER2, promotes human ovarian tumor cell activation. J Biol Chem. 1997;272(44):27913–27918. doi: 10.1074/jbc.272.44.27913 [DOI] [PubMed] [Google Scholar]
  • 47.Sun H, He S, Wen B, et al. [Effect of Biejiajian Pills on Wnt signal pathway molecules β-catenin and GSK-3β and the target genes CD44v6 and VEGF in hepatocellular carcinoma cells]. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(10):1454–1458. [PubMed] [Google Scholar]
  • 48.Xu Z, Zheng G, Wang Y, et al. Aqueous Huaier extract suppresses gastric cancer metastasis and epithelial to mesenchymal transition by targeting twist.. J Cancer. 2017;8(18):3876–3886. doi: 10.7150/jca.20380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wu J, Yu J, Wang J, et al. Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway. Biomed Pharmacother. 2018;100:176–183. doi: 10.1016/j.biopha.2018.01.140 [DOI] [PubMed] [Google Scholar]
  • 50.Jiao Y, Wang X, Li Y, et al. Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1. Oncol Rep. 2017;37(3):1394. doi: 10.3892/or.2017.5408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ishikawa M, Kitayama J, Kazama S, et al. Expression of vascular endothelial growth factor C and D (VEGF-C and-D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol. 2003;33(1):21–27. doi: 10.1093/jjco/hyg008 [DOI] [PubMed] [Google Scholar]
  • 52.Bao L, Liu F, Guo HB, et al. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway. Tumour Biol. 2016;37(8):11365–11374. doi: 10.1007/s13277-016-5013-2 [DOI] [PubMed] [Google Scholar]
  • 53.Liu W, Meng M, Zhang B, et al. Dehydroeffusol effectively inhibits human gastric cancer cell-mediated vasculogenic mimicry with low toxicity. Toxicol Appl Pharmacol. 2015;287(2):98. doi: 10.1016/j.taap.2015.05.003 [DOI] [PubMed] [Google Scholar]
  • 54.Mu J, Liu T, Jiang L, et al. The traditional Chinese medicine baicalein potently in hibits gastric cancer cells. J Cancer. 2016;7(4):453. doi: 10.7150/jca.13548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Qian Y, Lu S, Shi Y, et al. Celastrus orbiculatusextracts induce apoptosis and inhibit invasion by targeting the maspin gene in human gastric adenocarcinoma cells:. Oncol Lett. 2018;15(1):243–249. doi: 10.3892/ol.2017.7341 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 56.Lu Z, Long Y, Cun X, et al. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy. Nanoscale. 2018;10:9957–9970. [DOI] [PubMed] [Google Scholar]
  • 57.Kolb WP, Granger GA. Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A. 1970;1(1):122–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ruddle NH, Waksman BH. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism. J Exp Med. 1968;128(6):1267–1279. doi: 10.1084/jem.128.6.1267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies.. Nat Rev Rheumatol. 2016;12(1):49. doi: 10.1038/nrrheum.2015.169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. Aaps J. 2013;15(1):195–218. doi: 10.1208/s12248-012-9432-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Ji J, Wang HS, Gao YY, et al. Synergistic anti-tumor effect of KLF4 and curcumin in human gastric carcinoma cell line. Asian Pac J Cancer Prev. 2014;15(18):7747–7752. doi: 10.7314/apjcp.2014.15.18.7747 [DOI] [PubMed] [Google Scholar]
  • 62.Hamzehzadeh L, Atkin SL, Majeed M, et al. The versatile role of curcumin in cancer prevention and treatment: a focus on PI3K/AKT pathway. J Cell Physiol. 2018;2:825. [DOI] [PubMed] [Google Scholar]
  • 63.Shakibaei M, Kraehe P, Popper B, et al. Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer. 2015;15(1):1–15. doi: 10.1186/1471-2407-15-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Xie J, Lin Z, Xian Y, et al. (-)-Patchouli alcohol protects against Helicobacter pylori urease-induced apoptosis, oxidative stress and inflammatory response in human gastric epithelial cells.. Int Immunopharmacol. 2016;35:43. doi: 10.1016/j.intimp.2016.02.022 [DOI] [PubMed] [Google Scholar]

Articles from Cancer Management and Research are provided here courtesy of Dove Press

RESOURCES